Search

Washington, DC: In recognition of Hepatitis Testing Day this Friday May 19th, the American Academy of HIV Medicine (AAHIVM)’s Institute for Hepatitis C has partnered with the American College of Physicians (ACP) to release the brand new Guide to Hepatitis C Testing. The Guide to Hepatitis C Testing is designed to help clinicians screen patients for hepatitis C (HCV).  The Guide includes a summary of the latest testing recommendations, along with diagnostic, billing, and laboratory codes for testing.  It provides resources for referrals to HCV-experienced providers and information on patient interactions, education, and case examples. There are approximately 2.7-3.9 million people in the United...

HCV Testing & Screening Guide to Hepatitis C Testing AAHIVM along with the American College of Physicians (ACP) has developed a "Guide to Hepatitis C Testing" for clinical providers. The guide presents information on recommended testing populations, screening processes, laboratory and billing for diagnostic and confirmatory screening and also genotype testing. It also provides helpful guidance and examples on patients interactions and provision of information on hepatitis C. Download the PDF file: Guide to Hepatitis C Testing by AAHIVM and ACP   The Guide is also available in a free hard-copy brochure format for clinical providers and educational purposes. For brochure requests, contact: Ericka Nanalig, AAHIVM Office Manager CDC Testing Guidelines: The...

Hepatitis C Facts HIV & HCV Facts Currently the CDC estimates that there are 56,000 new cases of HIV transmission in the United States each year. Although there is no cure available for HIV disease currently, new available drug treatment options have the ability to effectively manage HIV patients disease to a state that is virtually undetectable with side effects like those of many common chronic conditions. Meanwhile, while the CDC estimates 12,000 deaths annually in the US from liver disease caused by hepatitis C. An estimated one-third of people with HIV in the U.S. are co-infected with HCV and liver disease is one...

HCV Treatment Guidelines Below are the most current HCV Treatment Guidelines published by the Infectious Diseases Society of America, WHO, and the U.S. Department of Veterans Affairs.HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C - The American Association for the Study of Liver Diseases (AASLD) WHO: Guidelines for the Screening, Care, and Treatment of Persons with Hepatitis C Infection - The World Health Organization VA: Guidelines and Best Practices - The U.S. Department of Veterans AffairsAdditional Resources:  Centers for Disease Control and Prevention (CDC) – Division of Viral Hepatitis  04.28.2017 CDC Testing Recommendations for Hepatitis C Virus Infection  04.28.2017 CDC Division of Viral Hepatitis “Hepatitis C FAQs for Health Professionals” 04.28.2017 World...

ABOUT THE AAHIVM INSTITUTE FOR HEPATITIS C With many of the 1.2 million HIV-infected Americans already in care for their HIV, HIV care providers are in a unique position to treat and likely cure hepatitis C in the approximately one-quarter who are co-infected. This Institute has been created by AAHIVM to help advance knowledge of HIV/HCV co-infection care through educational initiatives, prevention and testing information, relevant research and policy activities. Dr. Margaret Hoffman-Terry, Vice Chair of the AAHIVM Board of Directors, serves as Director of the Institute. AREAS OF INTEREST THE NEED FOR AN INSTITUTE FOR HEPATITIS C Research in hepatitis C has benefited greatly...

HIV TESTING CLINICAL HIV Testing The CDC estimates that there are 56,000 transmissions of HIV in the U.S. each year. Of this number, the CDC estimates that half of new infections are caused by persons who are unaware of their status. HIV screening among the general population is cost effective and the cost is comparable to other screenings and medical interventions. Many people with HIV/AIDS are diagnosed very late in the disease process and are unable to fully benefit from the lifesaving HIV treatments available today. An estimated 40 percent of individuals with HIV are diagnosed within one year of developing AIDS—when it is...

HIV Testing The CDC estimates that there are 56,000 transmissions of HIV in the U.S. each year. Of this number, the CDC estimates that half of new infections are caused by persons who are unaware of their status. HIV screening among the general population is cost effective and the cost is comparable to other screenings and medical interventions. Many people with HIV/AIDS are diagnosed very late in the disease process and are unable to fully benefit from the lifesaving HIV treatments available today. An estimated 40 percent of individuals with HIV are diagnosed within one year of developing AIDS—when it is often too...

HIV PHARMACIST™ HIV Pharmacist™ (AAHIVP) – pharmacists working in HIV-specific care environments ELIGIBILITY LICENSURE:   Maintain a current, valid Pharmacist license in the state or region of practice; must have graduated from an accredited school of pharmacy. Qualified international providers are eligible. If you are not a practicing pharmacist, you may be eligible for the HIV Expert designation. EXPERIENCE:  Direct, ongoing involvement in the care of at least 20 HIV patients within the 24 months preceding the date of application. This requirement may be fulfilled in any of the following ways: Direct clinical client services, consultation or case review in an inpatient or outpatient clinic or...

HIV EXPERT™ HIV Expert™ (AAHIVE) –physicians, physician assistants, nurse practitioners and pharmacists working in non-clinical environments ELIGIBILITY LICENSURE:   Maintain a current, valid MD, DO, PA, NP or Pharmacist state license EXPERIENCE:  Direct, ongoing involvement or leadership in HIV care and treatment over the 24 months preceding the date of application, through service in one of the following realms: Pharmaceutical Industry (admin/research/medical affairs) Academia (admin/faculty) Government (FDA, NIH, VA, CDC, military, etc.) Other non-clinical environments without direct patient care activity For each of these professional environments, applicants should be working in close proximity to or in direct contact with other clinical providers who do actively maintain direct patient contact. ...

PROVIDER RESOURCES Through the programs in this section, the American Academy of HIV Medicine strives to meet the needs of HIV care providers, their practices and their patients. Clinical Information Learn about emerging topics in HIV and HCV medicine, including the latest testing and treatment guidelines. Institute for Hepatitis C This Institute has been created by AAHIVM to help advance knowledge of HIV/HCV co-infection care through educational initiatives, prevention and testing information, relevant research and policy activities. HIV and Aging Learn more about our HIV and aging initiative with ACRIA and the American Geriatrics Society, including treatment recommendations and HIV-Age.org. Patient Assistance Many HIV patients face obstacles accessing care,...